Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD80 anticorps (AA 35-142)

Cet anticorps anti-CD80 est un anticorps Souris Monoclonal détectant CD80 dans ELISA, Coat et IHC (f). Adapté pour Humain.
N° du produit ABIN7127180

Aperçu rapide pour CD80 anticorps (AA 35-142) (ABIN7127180)

Antigène

Voir toutes CD80 Anticorps
CD80

Reactivité

  • 177
  • 120
  • 46
  • 8
  • 6
  • 6
  • 1
  • 1
  • 1
Humain

Hôte

  • 103
  • 97
  • 28
  • 21
  • 20
  • 2
  • 1
Souris

Clonalité

  • 187
  • 82
  • 2
Monoclonal

Conjugué

  • 105
  • 21
  • 20
  • 19
  • 14
  • 7
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD80 est non-conjugé

Application

  • 161
  • 96
  • 73
  • 41
  • 39
  • 26
  • 13
  • 13
  • 13
  • 13
  • 11
  • 10
  • 9
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 16
    • 15
    • 13
    • 12
    • 8
    • 7
    • 6
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 35-142

    Specificité

    T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31 % overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment of human CD80 protein (around aa 35-142) (exact sequence is proprietary)

    Isotype

    IgG2b
  • Indications d'application

    Known_Application: ELISA (For coating, order Ab without BSA), ,Immunohistochemistry (Formalin-fixed) (2-4 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Rajior Ramos cells. Human tonsil, spleen or thymus.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    CD80

    Autre désignation

    CD80

    Sujet

    Activation B7-1 antigen, B lymphocyte activation antigen B7, B7, B7-1, BB1, CD28 antigen ligand 1, CD28LG, CD28LG1, CD80, Costimulatory factor CD80, CTLA-4 counter-receptor B7.1, LAB7, T-lymphocyte activation antigen CD80,CD80 (B7-1)
    Cellular localisation: Cell Surface

    Poids moléculaire

    60kDa

    ID gène

    941, 838

    UniProt

    P33681

    Pathways

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!